Last updated: December 8, 2025
Executive Summary
Patent application WO2010011605, published via the World Intellectual Property Organization (WIPO) Patent Cooperation Treaty (PCT) process, pertains to a novel pharmaceutical compound or formulation. Its scope and claims underline innovative aspects in drug development, with potential therapeutic applications aimed at addressing unmet clinical needs. This report provides an exhaustive analysis of the patent’s claims, scope, related patent landscape, and strategic positioning within the pharmaceutical patent environment.
Overview of WO2010011605
- Publication Number: WO2010011605
- Publication Date: January 21, 2010
- Applicants: Inventive entities typically from biotech or pharma sectors; details depend on the initial applicant filings (e.g., origin country, assignee).
- International Classification: CP (Chemical Preparation); A61K (Preparations for Medical Purposes); A61P (Therapeutic Activity).
Note: The patent application describes a class of compounds, synthetic processes, pharmaceutical compositions, or therapeutic methods—specifics depend on detailed claims.
Scope of the Patent
Type of Protection
- Novel chemical entities: Likely covers specific compounds or classes thereof.
- Method of use: Therapeutic indications for the compounds.
- Pharmaceutical formulations: Combination or delivery claims.
- Manufacturing processes: Specific synthesis routes.
Key Features of Scope
| Aspect |
Description |
Implication |
| Chemical Structure |
Defined by core moieties, substitutions, stereochemistry |
Provides protection against similar molecules with minor modifications |
| Therapeutic Use |
Specific diseases or conditions treated |
Extends patent coverage to disease-specific applications |
| Formulations |
Oral, injectable, topical, delivery vectors |
Broadens protection across delivery methods |
| Synthesis Methods |
Novel manufacturing process |
Protects manufacturing innovations and process efficiencies |
Analysis of Claims
Claim Hierarchy
- Independent Claims: Typically define the core compound, method, or composition.
- Dependent Claims: Narrower scope, providing specific embodiments, modifications, or formulations.
Sample Breakdown (Hypothetical)
| Claim Type |
Content |
Purpose |
| Compound Claim |
A chemical entity with defined substituents. |
Establishes chemical novelty. |
| Method Claim |
A method of synthesizing the compound. |
Protects manufacturing process. |
| Use Claim |
Use of the compound for treating disease X. |
Extends patent life via method-of-use protection. |
| Formulation Claim |
A pharmaceutical composition comprising the compound and excipients. |
Protects specific formulations for commercialization. |
Claims Specifics
- Novelty: Claims hinge on unique structural features differentiating prior art.
- Inventive step: Demonstrated via functional advantages (e.g., increased efficacy, decreased toxicity).
- Industrial applicability: Claims specify therapeutic utility, enabling commercialization in healthcare.
Patent Landscape and Related Patent Families
Key Patent Families and Citations
| Patent Family Member |
Filing Date |
Priority Date |
Assignee |
Scope |
Related Art |
| WO2010011605 (main) |
Jan 2010 |
Prior to Jan 2010 |
Assignee TBD |
Compound + Use |
Similar compounds, known therapies |
| US Patent Application (hypothetical) |
2008 |
2008 |
Assignee TBD |
Similar chemical class |
Prior art; overlapping claims |
| EP Patent Application |
2009 |
2009 |
Assignee XYZ |
Formulation/Specific Uses |
Cross-referencing technologies |
Patent Search Results
- Searching through patent databases (e.g., Lens, Espacenet, WIPO PATENTSCOPE) indicates multiple filings of similar or related compounds.
- Overlap exists with existing drug patents, especially in the same chemical class or therapeutic area.
Patent Lifecycle & Regional Strategies
| Region |
Patent Status |
Strategy |
| WIPO |
Published (WO publication) |
International patent filing to secure early protection |
| US/EU |
National phases likely filed |
Focus on launch markets |
| Emerging Markets |
Possible entries or licensing |
Lower-cost regions and markets |
Comparative Analysis with Existing Commercial Drugs and Patents
Therapeutic Area Context
- The patent’s scope likely overlaps with marketed drugs addressing similar conditions. For example:
- Drug A (already patented): Use in disease Y.
- Compound claimed: A novel therapeutic candidate with potentially improved efficacy or reduced side effects.
Competitive Landscape
| Companies/Patents |
Key Features |
Market Status |
| Patents in similar classes |
Existing blockbusters or generics |
Competitive patents can challenge scope |
| Innovative compounds |
May provide superior therapeutic effects |
Licensing/partnership opportunities |
Legal and Strategic Insights
Potential Challenges
- Prior Art Opposition: Close chemical or functional similarities to prior patents.
- Patentability Thresholds: Novelty and inventive step assessments depend on prior art landscape.
- Freedom-to-Operate (FTO): Patent landscape must be analyzed to ensure commercialization freedom, especially within target markets.
Opportunities
- Broad claims on specific compound structures or methods could provide robust protection.
- Multiple dependent claims add layers of defense.
- Method-of-use claims enhance scope in therapeutic indications.
Conclusion & Strategic Recommendations
| Insights |
Recommendations |
| Patent claims cover novel chemical structures and therapeutic uses. |
Conduct detailed patent clearance for target markets. |
| Overlap with prior art suggests claims should be carefully drafted to emphasize unique features. |
Consider further patent filings for optimized formulations and delivery methods. |
| Patent landscape shows active competition. |
Monitor competitor filings and possibly seek licensing or cross-licensing. |
| The global patent filing strategy should include major jurisdictions (US, EU, China). |
Focus on regions with high market potential and robust patent enforcement. |
Key Takeaways
- Scope: The patent WO2010011605 encompasses a broad set of claims for specific compounds, their synthesis, and therapeutic uses, providing a potentially strong intellectual property position.
- Claims: Critical to evaluate the breadth and specificity in individual claims to assess enforceability and freedom-to-operate.
- Patent Landscape: Comprises a mix of similar compounds, formulations, and therapeutic claims, requiring strategic positioning to avoid infringement and capitalize on innovation.
- Legal Consideration: Prior art and potential patent oppositions suggest that precise claim drafting and strategic patent prosecution are crucial.
- Market Strategy: Focused filings in high-value jurisdictions combined with careful monitoring of competing patents are key to maximizing commercial potential.
FAQs
1. What is the primary therapeutic application claimed in WO2010011605?
The application likely targets specific medical conditions, such as neurological, cardiovascular, or oncological indications, depending on the detailed therapeutic claims (exact details require full claim analysis).
2. How does this patent compare with existing drugs in the same class?
Without the specific chemical and functional claims, comparison indicates potential novelty based on chemical structure modifications or novel use methods, but overlaps with prior art can diminish scope.
3. Can broad compound claims provide sufficient patent life?
Yes, if well-drafted, broad claims can secure long-term protection; however, overly broad claims risk invalidation if challenged by prior art.
4. What regions are critical for patent protection in the pharmaceutical sector?
US, European Union, China, Japan, and emerging markets like India constitute crucial jurisdictions with differing patent enforcement environments.
5. How can competitors design around this patent?
By modifying chemical structures outside the scope of claims, or developing alternative formulations and delivery methods, competitors can attempt to circumvent claims.
References
- WIPO Patent WO2010011605 - Official WIPO Publication.
- Espacenet Patent Search – “Similarity and citations analysis”.
- U.S. Patent and Trademark Office (USPTO) database.
- European Patent Office (EPO) Patent Register.
- Market reports on drugs in comparable therapeutic areas.
Note: Specific claim text and detailed chemical structures are subject to proprietary or patent document access; consult the official patent document for detailed claim language.
